Home Depot has now reported its Q1 numbers, and the immediate analyst response tells the story: broad target cuts, preserved ratings, and a stock that has recovered only fractionally from its pre-earnings lows.
The earnings event landed on May 19, with HD closing the following day at $302.44 — up less than 1% on the day, but still down 2.6% on the week and 13.4% on the month. The most recent comparable print, the February Q4 release, delivered a 1-day move of -2.8% and a five-day move of -2.9%. The post-Q1 recovery has been modest by comparison. Nearest peer LOW tracked similarly, off 2.7% on the week. FND fared worse, down 7.2%, while HVT was the sole outlier in the group, managing a 2.5% weekly gain — a reminder that the weakness is concentrated in larger-format home improvement names rather than the category broadly.
The analyst community's reaction to the print was uniform in direction, if not magnitude. Every firm that moved today cut its price target. Morgan Stanley lowered to $400 from $420 while holding Overweight. UBS trimmed to $430 from $450, also keeping Buy. TD Cowen made the sharpest reduction — down to $375 from $450 — again without pulling its Buy rating. Piper Sandler, Truist, DA Davidson, Wells Fargo, and RBC all followed the same pattern: lower targets, unchanged ratings. The consensus mean now stands at $373, implying roughly 23% upside from the current price. That's a meaningful gap, but the momentum behind those targets has been in one direction for weeks. The bull case rests on professional contractor demand, digital investment, and MRO acquisition optionality. The bear case, which Truist and RBC implicitly acknowledged by cutting to $369 and $340 respectively, points to housing affordability drag, soft big-ticket discretionary demand, and ongoing tariff pressure on sourcing costs.
Options positioning shifted visibly after the print. The put/call ratio has edged higher to 0.77, still around 1.4 standard deviations below its 20-day mean of 0.85 — but the extreme call skew seen in the run-up to earnings (PCR briefly touched 0.73, near the 52-week low of 0.70) has partially normalised. The options market was effectively pricing in a relief rally; the modest 0.9% one-day bounce suggests the print delivered something closer to an in-line read than an outright beat. The lending market adds little to the story. Short interest is just 1.1% of the free float — down 7% over the past month — and borrow availability is effectively unconstrained, with no meaningful pressure in the short book either way.
The PE multiple has compressed to roughly 19.6x, down about 3 points over 30 days. EV/EBITDA is near 14x. These are more reasonable entry levels than the stock has offered for some time, but factor scores reflect the duality: dividend score ranks in the 82nd percentile, a sign of financial durability, while EPS momentum scores at just 40 — the forward earnings revisions have been drifting lower. The short score has also eased steadily, from 30.9 a week ago to 30.1 today, confirming that bearish positioning pressure is receding even as the price has lagged.
The next earnings date is flagged at May 21, though the data likely reflects a re-scheduled or adjusted filing window post-Q1. What the market will now focus on is whether the guidance commentary from the Q1 call — specifically around the fiscal 2026 comp sales outlook — holds up against further tariff developments and any change in housing activity through the summer.
See the live data behind this article on ORTEX.
Open HD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
